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Abstract
Parkinson’s disease (PD) is the most common age associated
neurodegenerative disease, which has been extensively studied for its
etiology and phenotype. PD has been widely studied in alternate model
system such as rodents towards understanding the role of neurotoxin by
inducing PD. This study is aimed to understand the biomechanism of PD
in zebrafish model system induced by 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP). The phenotype and role of various genes
and proteins for Parkinsonism were tested and evaluated in this study
using behaviour, molecular and proteomic approaches. Zebrafish PD
model induced by 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine showed
a significant level of decrease in the movement with erratic swimming
pattern and increased freezing bouts. CHCHD2, EEF2B, LRRK2,
PARK7, PARK2, POLG, SNCGB and SYNB genes were differentially
regulated at the transcript level in PD zebrafish. Similarly a total of 73
proteins were recognized as differentially expressed in the nervous
system of zebrafish due to Parkinsonism based on quantitative
proteomics approach. Proteins such as NEFL,MUNC13-1, NAV2 and
GAPVD1 were down regulated in the zebrafish brain for the PD
phenotype, which were associated with the neurological pathways. This
zebrafish based PD model can be used as a potential model system for
screening prospective drug molecules for PD.
 Behaviour analysis of MPTP
induced PD phenotype in
zebrafish. Effects of MPTP on
number of crosses (A), number
of freezing bouts (B), freezing
duration (C) and distance
travelled (D) in water.
 MPTP treated zebrafish
revealed decrease in number of
crosses, increased number of
freezing bouts, freezing
duration and decreased
swimming movement.
 Heat map view of protein
expression in PD induced
zebrafish brain. The protein
expressions were calculated
based on 2 log fold changes in
protein expression based
iTRAQ analysis between the
control and 1‐dose MPTP
treatment and control and
2‐dose of MPTP treatment. The
hierarchical cluster heat map
expression was calculated
using R program.
 Proteins such as NEFL and
Plectin 1 were found down
regulated in zebrafish brain,
which were found to be
involved in cytoskeleton
remodelling of neurofilaments,
the major intermediate
filaments of the neurons.
 The cyclin-dependent kinase
(CDK5), which has a major role
in neuronal development and
differentiation, was also found
associated with PD in zebrafish
by the down regulation of NEFL
protein
 Network pathway map analysis obtained from the differentially expressed
proteome of PD zebrafish brain. (A) Cytoskeleton remodelling of
neurofilaments, (B) role of CDK5 in neuronal development, (C)
neurophysiological synaptic vesicle fusion and (D) GABA‐B receptor
signalling in presynaptic nerve terminals pathway. The blue colour
thermometer indicates the down‐regulation of the proteins identified in
the study.
 Relative expression of PD genes based on quantitative RT‐PCR analysis.
The relative expression of genes was shown for M1 and M2 dose of MPTP
in zebrafish brain against the control expression. The gene expression
were shown in 2 log fold changes of mean ± SEM. *p < 0.05 vs. control
group, **p < 0.01 vs. control group, (one‐way ANOVA post test, n = 3).
Results Results
 Western blot expression
analysis of the PD markers,
SNCA, PARK8, DJ1 and
tyrosine hydroxylase protein.
The expression levels of the
proteins were calculated based
on band quantification analysis
using Image J software. Protein
expression was shown at a
basal level of 1 fold and
statistical significance was
estimated as the mean ± SEM.
*p < 0.05 vs. control group
(one‐way ANOVA post test,
N = 2).
 Immunofluorescence analysis of the SNCA protein expression in the
cross section of the zebrafish optic tectum. (A) Expression pattern of
SNCA, neuronal tubulin, DAPI staining and Merge image, (B) expression
patter of tyrosine hydroxylase, (C) relative expression of SNCGA/B
protein and (D) relative expression of tyrosine hydroxylase. The analyses
were performed on control; M1 and M2 MPTP treated optic tectum
sections. The expression was shown as relative expression against
control with mean ± SEM. *p < 0.05 vs. control group (one‐way ANOVA
post test, N = 3).
 Behaviour analysis of deprenyl
treated PD zebrafish. (A) Effects
of MPTP and deprenyl treatment
for number of crosses, (B)
number of freezing bouts and (C)
freezing duration of PD zebrafish.
 Numbers of crosses were found
significantly recovered in M1
group for both 1 and 2-dose of
deprenyl. Similarly 2-dose
deprenyl showed significant
reduction in number of freezing
bouts and freezing duration in M1
PD. The recovery of PD
phenotype in M2 was found mildly
and non-significantly retrieved
upon deprenyl treatment.
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 The phenotype and role of various genes and proteins involved in
Parkinsonism was identified in the MPTP induced zebrafish PD model
based on behavioural, molecular and proteomics approaches. CHCHD2,
EEF2B, LRRK2, PARK7, PARK2, POLG, SNCGB and SYNB were found
associated with Parkinsonism in zebrafish PD model. The model can be
used as a potential neurological model for PD study.
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 To establish the zebrafish as a model organism for studying the
Parkinson's Disease.
 To understand the MPTP induced PD in adult wild zebrafish nervous
system involving behavioural, transcriptomics and proteomics studies.
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 This study through quantitative proteomic analysis has established
association of 78 proteins as differentially regulated in the zebrafish
brain induced with MPTP for PD phenotype.
 mRNA expression analysis confirms the Parkinsonism in the MPTP
treated zebrafish with up regulation of a group of molecular markers
such as CHCHD2, CRF, DNM2A, EIF4G1, SNCGA, SNCGB, SNCB, etc.
 The model of PD in zebrafish has not only established an alternate
model for the PD but a potential model for screening drug targets for an
effective treatment against the disease. The markers established in this
study associated for the disease can be used as biomarkers for the
disease and as screening targets for potential PD drugs.
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